Search Header Logo

Diabetes: Oral Meds

Authored by Taylor Austin

Other

University

Used 24+ times

Diabetes: Oral Meds
AI

AI Actions

Add similar questions

Adjust reading levels

Convert to real-world scenario

Translate activity

More...

    Content View

    Student View

10 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which of the following classes is first line for T2DM?

Biguanides

TZDs

DPP-4 Inhibitors

SGLT-2 Inhibitors

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

TZDs (Pioglitazone + Rosiglitazone) carry the following risks, EXCEPT

Weight Gain

Bladder Cancer

Anovulation

Fluid Retention / Heart Failure

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

T/F: Glimepiride, Glipizide, and Glyburide are the Sulfonylureas available to patients with an allergy to sulfa

True

False

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

A patient on Nateglinide or Repaglinide (Metglinide class) should only skip a dose if ….

Their BG is <150

They are fasting

They consumed two slices of pizza

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which one of the following DPP-4 Inhibitors does not require renal dose adjustment?

Sitagliptin (Januvia)

Saxagliptin (Onglyza)

Linagliptin (Tradjenta)

Alogliptin (Nesina)

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

This class of medications is required to be taken with the first bite of food.

SGLT-2 (ex. Canagliflozin)

AGIs (ex. Acarbose)

SURs (ex. Glyburide)

TZDs (ex. Pioglitazone)

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

SGLT-2 Inhibitors [Invokana, Farxiga, Jardiance, Steglarto] carry the following risks, EXCEPT

BP elevation

UTIs

Lower Limb Amputation

Dehydration

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?